Evidence map›Paper›PMID 28945413›Full record

ArticleAccounts of chemical research2017

From Fuzzy to Function: The New Frontier of Protein-Protein Interactions.

Rachel Pricer, Jason E Gestwicki, Anna K Mapp

Abstract read
In one paragraph

Article in Accounts of chemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. New inhibitors of themSphere · 2026
    Article
  2. Use of Computational Models to Investigate Human Targets of Small Ubiquitous Molecules.Chembiochem : a European journal of chemical biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Molecular Docking and Molecular Dynamics Simulations in Related toTropical medicine and infectious disease · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Norstictic Acid Is a Selective Allosteric Transcriptional Regulator.Journal of the American Chemical Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel PricerLife Sciences Institute, University of Michigan , Ann Arbor, Michigan 48109-2216, United States.
Jason E GestwickiInstitute for Neurodegenerative Diseases, Department of Pharmaceutical Chemistry, University of California-San Francisco , San Francisco, California 94143-0518, United States.
Anna K MappLife Sciences Institute, University of Michigan , Ann Arbor, Michigan 48109-2216, United States.ORCID 0000-0003-0791-8327

Funding

MICHIGAN CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008597 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN · 1996 to 2018
$5.0M
Probing Transcriptional Activation at the Molecular Level - Equipment SupplementR01GM065330 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MAPP, ANNA K. · 2002 to 2019
$4.2M
NIGMS NIH HHS R01 GM065330NIGMS NIH HHS T32 GM008597
6 · The paper itself

Abstract

Conformationally heterogenous or "fuzzy" proteins have often been described as lacking specificity in binding and in function. The activation domains, for example, of transcriptional activators were labeled as negative noodles, with little structure or specificity. However, emerging data illustrates that the opposite is true: conformational heterogeneity enables context-specific function to emerge in response to changing cellular conditions and, furthermore, allows a single structural motif to be used in multiple settings. A further benefit is that conformational heterogeneity can be harnessed for the discovery of allosteric drug-like modulators, targeting critical pathways in protein homeostasis and transcription.

Indexed as

Fuzzy LogicProtein Interaction MapsProtein ConformationProteinsStructure-Activity RelationshipProteins

Identifiers

PMID28945413
PMCPMC5786153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.